Your session is about to expire
← Back to Search
CorNeat KPro for Corneal Diseases
Study Summary
This trial is testing a new synthetic cornea to see if it is safe and effective in treating corneal blindness.
- Corneal Diseases
- Corneal Opacity
- Corneal Injury
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Is enrollment open to people under the age of twenty for this experiment?
"This clinical trial requires applicants to be aged between 18 and 80. For those patients outside of this age range, there are 13 trials catered specifically for minors and 39 studies tailored towards seniors."
What is the estimated participant count for this trial?
"To meet the requirements of this trial, 40 individuals who fit the study's eligibility standards must participate. These participants can come from several different locations such as Cincinnati Eye Institute in Edgewood and UHN - University Health Network in Toronto."
How many healthcare locations in Canada are currently engaged with this trial?
"Patients can be enrolled in this trial at Cincinnati Eye Institute located in Edgewood, Kentucky; UHN - University Health Network situated in Toronto, Ontario; and the University of British Columbia based out of Vancouver, British Columbia. Plus there are four other participating locations."
Is it possible for me to partake in this medical research?
"This medical trial is enrolling 40 individuals aged between 18 and 80 who suffer from corneal opacity. Expectant mothers must provide a negative pregnancy test at the screening stage, while all participants are required to have an understanding of light in each quadrant. Male or female candidates need to be capable and willing to attend scheduled visits and follow through with associated study requirements. Those ineligible for keratoplasty due to prior failed transplantations, herpetic keratitis, vascularized scarring, OCP and other conditions may qualify for this project as long as they do not possess pseudophakia."
Are recruitments for this experiment open at the moment?
"Data is readily available from clinicaltrials.gov that confirms the current recruitment status of this medical trial. The initial posting was on March 1, 2021 and subsequent updates were made as recently as April 24, 2022."
Who else is applying?
What state do they live in?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Why did patients apply to this trial?
Share this study with friends
Copy Link
Messenger